Manipulating The Immune System For Therapeutic PDF

You might also like

Download as pdf or txt
Download as pdf or txt
You are on page 1of 15

Charles A.

Janeway, Paul Travers, Mark Walport, Mark Shlomchik

Immunobiology:
The Immune System in Health & Disease
Sixth Edition

Chapter 14
Manipulation of the Immune Response

Copyright © 2005 by Garland Science Publishing

The structure of the anti-inflammatory corticosteroid drug prednisone

1
Mechanism of steroid action

Anti-inflammatory effects of corticosteroid therapy

2
Cyclosporin A and tacrolimus inhibit T-cell activation by interfering with
the serine/threonine-specific phosphatase calcineurin

Cyclosporin A and tacrolimus inhibit T-cell activation by interfering with


the serine/threonine-specific phosphatase calcineurin

3
Cyclosporin A and tacrolimus inhibit lymphocyte and
some granulocyte responses

Anti-inflammatory effects of anti-TNF-α therapy in rheumatoid arthritis

4
Natalizumab, a therapeutic anti-alpha4 integrin mAb
N
a
Figure 14-8
for the treatment of MS and IBD

t
a
l
i
z
u
m
a
b

Natalizumab, an therepeutic anti-alpha4 integrin mAb


for the treatment of MS and IBD
Figure 14-8 part 1 of 2

5
Figure 14-8 part 2 of 2

6
Tumor rejection antigens are specific to individual tumors

Figure 14-10 part 1 of 2

7
Figure 14-10 part 2 of 2

Proteins selectively expressed in human tumors are candidate


tumor rejection antigens

8
Tumor rejection antigens may arise by point mutations in self proteins,
which occur during the process of oncogenesis

Tumor rejection antigens are peptides of cell proteins presented by


self MHC class I molecules

9
Tumors can escape immune surveillance in a variety of ways

Loss of MHC class I expression in a prostatic carcinoma

10
Tumors that lose expression of all MHC class I molecules as a mechanism
of escape from immune surveillance are more susceptible to NK cell killing

Monoclonal antibodies that recognize tumor-specific antigens might be used


in a variety of ways to help eliminate tumors

11
Examples of tumor antigens that have been targeted by monoclonal
antibodies in therapeutic trials

Transfection of tumors with the gene for B7 or for GM-CSF enhances


tumor immunogenicity

12
Transfection of tumors with the gene for B7 or for GM-CSF enhances
tumor immunogenicity

Recommended childhood vaccination schedules (in red) in the United States

13
Diseases for which effective vaccines are still needed

There are several criteria for an effective vaccine

14
Viruses are traditionally attenuated by selecting for growth in nonhuman cells

Attenuation can be achieved more rapidly and reliably with recombinant


CNA techniques

15

You might also like